Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Somatoform Disorders 1Peripheral Nervous System Diseases 1Breast Neoplasms 1Breast Neoplasm Female 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Etoricoxib × Breast × Clear all
NCT04565600 2022-02-14

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Guangdong Provincial People's Hospital

Phase 2 Completed
144 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Somatoform Disorders

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed
200 enrolled
Breast

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡